Publications in journals

T. Tukiainen, T. Tynkkynen, V.-P. Mäkinen, P. Jylänki, A. Kangas, J. Hokkanen, A. Vehtari, O. Gröhn, M. Hallikainen, H. Soininen, M. Kivipelto, P.-H. Groop, K. Kaski, R. Laatikainen, P. Soininen, T. Pirttilä, M. Ala-Korpela A multi-metabolite analysis of serum by 1H NMR spectroscopy: early systemic signs of Alzheimer's disease Biochemical and Biophysical Research Communications 375, 356-361, 2008

T. Liimatainen, J. M. Hakumäki, R. A. Kauppinen, M. Ala-Korpela Monitoring of gliomas in vivo by diffusion MRI and 1H MRS during gene therapy induced apoptosis – interrelationships between water diffusion and mobile lipids NMR in Biomedicine 2008, in press

V.-P. Mäkinen, C. Forsblom, L. Thorn, J. Wadén, D. Gordin, O. Heikkilä, K. Hietala, L. Kyllönen, J. Kytö, M. Rosengård-Bärlund, M. Saraheimo, N. Tolonen, M. Parkkonen, K. Kaski, M. Ala-Korpela, P.-H. Groop Metabolic phenotypes, vascular complications and premature deaths in a population of 4,197 patients with type 1 diabetes Diabetes 57, 2480-2487, 2008

L. S. Kumpula, J. M. Kumpula, M.-R. Taskinen, M. Jauhiainen, K. Kaski, M. Ala-Korpela Reconsideration of hydrophobic lipid distributions in lipoprotein particles Chemistry and Physics of Lipids 155, 57-62, 2008

S. M. Mäkelä, M. Jauhiainen, M. Ala-Korpela, J. Metso, T. M. Lehto, M. J. Savolainen, M. L. Hannuksela HDL2 of heavy alcohol drinkers enhances cholesterol efflux from RAW-macrophages via enlarged phospholipid-rich HDL2b particles Alcoholism: Clinical and Experimental Research 32, 991-1000, 2008

V.-P. Mäkinen, P. Soininen, C. Forsblom, M. Parkkonen, P. Ingman, K. Kaski, P.-H. Groop, M. Ala-Korpela 1H NMR metabonomics approach to the disease continuum of diabetic complications and premature death Molecular Systems Biology 4, 167 (1-12), 2008

Featured article of the month in February 2008.

M. Ala-Korpela Critical evaluation of 1H NMR metabonomics of serum as a methodology for disease risk assessment and diagnostics Clinical Chemistry and Laboratory Medicine 46, 27-42, 2008

M. Ala-Korpela The potential role of body fluid 1H NMR metabonomics as a prognostic and diagnostic tool Expert Review of Molecular Diagnostics 7, 761-773, 2007

P. Soininen, K. Öörni, H. Maaheimo, R. Laatikainen, P. T. Kovanen, K. Kaski, M. Ala-Korpela 1H NMR at 800 MHz Facilitates Detailed Phospholipid Follow-Up during Atherogenic Modifications in Low Density Lipoproteins Biochemical and Biophysical Research Communications 360, 290-294, 2007

A. Vehtari, V.-P. Mäkinen, P. P. Soininen. Ingman, S. M. Mäkelä, M. J. Savolainen, M. L. Hannuksela, K. Kaski, M. Ala-Korpela A novel Bayesian approach to quantify clinical variables and to determine their spectroscopic counterparts in 1H NMR metabonomic data BMC Bioinformatics 8, (Suppl 2):S8, 2007

V.-P. Mäkinen, P.-H. Groop, M. Ala-Korpela Metabonomik – på väg mot individuell riskbedömning (in Swedish) Finska Läkaresällskapets Handlingar 167, 40-46, 2007

T. Suna, A. Salminen, P. Soininen, R. Laatikainen, P. Ingman, S. Mäkelä, M. J. Savolainen, M. L. Hannuksela, M. Jauhiainen, M.-R. Taskinen, K. Kaski, M. Ala-Korpela 1H NMR metabonomics of plasma lipoprotein subclasses - elucidation of metabolic clustering by self-organising maps NMR in Biomedicine 20, 658-672, 2007

M. Ala-Korpela, N. Lankinen, A. Salminen, T. Suna, P. Soininen, R. Laatikainen, P. Ingman, M. Jauhiainen, M.- R. Taskinen, K. Héberger, K. Kaski The inherent accuracy of 1H NMR spectroscopy to quantify plasma lipoproteins is subclass dependent Atherosclerosis 190, 352-358, 2007

V.-P. Mäkinen, P. Soininen, C. Forsblom, M. Parkkonen, P. Ingman, K. Kaski, P.-H. Groop, M. Ala-Korpela Diagnosing diabetic nephropathy by 1H NMR metabonomics of serum Magnetic Resonance Materials in Physics, Biology and Medicine 19, 281-296, 2006

T. Liimatainen, K. Lehtimäki, M. Ala-Korpela, J. Hakumäki Identification of mobile cholesterol compounds in experimental gliomas by 1H MRS in vivo: effects of ganciclovir-induced apoptosis on lipids FEBS Letters 580, 4746-4750, 2006

M. Ala-Korpela, P. Sipola, K. Kaski Molecular detection and characterisation of atherothrombosis by magnetic resonance - potential tools for individual risk assessment and diagnostics Annals of Medicine 38, 322-336, 2006

T. Suna, M. Hardey, J. Huhtinen, Y. Hiltunen, K. Kaski, J. Heikkonen, M. Ala-Korpela Self-organising map approach to individual profiles: age, sex and culture in Internet dating Sociological Research Online 11, Issue 1, 2006

K. Öörni, P. Posio, M. M. Ala-Korpela. Jauhiainen, P. T. Kovanen Sphingomyelinase induces aggregation and fusion of small VLDL and IDL particles and increases their retention to human arterial proteoglycans Arteriosclerosis, Thrombosis, and Vascular Biology 25, 1678-1683, 2005

In relation to this paper, Arteriosclerosis, Thrombosis, and Vascular Biology published an editorial by Kevin Jon Williams and Ira Tabas entitled Lipoprotein retention — and clues for atheroma regression; Arterioscler Thromb Vasc Biol 25, 1536–1540, 2005. (Article in PubMed)

More information

Dr Mika Ala-Korpela
Group Leader in Computational Medicine

The Academy of Finland Centre of Excellence in Computational Complex Systems Research 2006-2011

Helsinki University of Technology
Faculty of Information and Natural Sciences
Department of Biomedical Engineering and Computational Science
P.O. Box 9203
FI-02015 HUT
Finland    &

The Folkhälsan Research Center
Institute of Genetics, Department of Diabetes Genetics
The FinnDiane Study Group
P.O. Box 63, Biomedicum
00014 University of Helsinki
Finland    &

Helsinki University Central Hospital, Department of Medicine,
Division of Nephrology, Helsinki, Finland

Mobile: + 358 50 35 35 457
E-mail: